Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites, which include fleas, ticks, and worms. It also provides other pharmaceutical products that comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives, which offer medicines to livestock. In addition, the company provides portable blood and urine analysis testing, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision animal health. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.

Zoetis Inc.

Revenue

EBIT

EBITDA

CapEx

Net Interest Income

Assets

Adjusted EBITDA

Gross Profit

Adjusted Net Income

Net Revenue

Net Income

Average Assets

Adjusted EBIT

Adjusted Revenue

Adjusted EBT

Adjusted Funds From Operations

US Gross Profit

US Gross Profit % Chg.

US Gross Profit Common Size

International Gross Profit

International Gross Profit % Chg.

International Gross Profit Common Size

Other Gross Profit by Geography

Other Gross Profit by Geography % Chg.

Other Gross Profit by Geography Common Size

Total Gross Profit by Geography

Total Gross Profit by Geography Common Size

Total Gross Profit by Geography % Chg.

Gross Profit by Geography

Contract Manufacturing & Human Health Revenue

Contract Manufacturing & Human Health Revenue % Chg.

Contract Manufacturing & Human Health Revenue Common Size

US Revenue

US Revenue % Chg.

US Revenue Common Size

International Revenue

International Revenue % Chg.

International Revenue Common Size

Total Revenue by Geography

Total Revenue by Geography Common Size

Total Revenue by Geography % Chg.

Revenue by Geography

Companion Animal Revenue

Companion Animal Revenue % Chg.

Companion Animal Revenue Common Size

Livestock Revenue

Livestock Revenue % Chg.

Livestock Revenue Common Size

Total Revenue

Total Revenue Common Size

Total Revenue % Chg.

Revenue	LTM	Dec '24	Dec '23
Companion Animal Revenue	6,556	6,278	5,576
Livestock Revenue	2,734	2,898	2,890
Contract Manufacturing & Human Health Revenue	107	80	78
Total Revenue	9,397	9,256	8,544

Revenue by Geography	LTM	Dec '24	Dec '23
Contract Manufacturing & Human Health Revenue	107	80	78
US Revenue	5,118	5,074	4,555
International Revenue	4,172	4,102	3,911
Total Revenue by Geography	9,397	9,256	8,544

Gross Profit by Geography	LTM	Dec '24	Dec '23
US Gross Profit	4,260	4,138	3,655
International Gross Profit	2,889	2,790	2,677
Other Gross Profit by Geography	-413	-391	-349
Total Gross Profit by Geography	6,736	6,537	5,983